易布洛芬是否与上部胃肠道出血有关? 一个系统的审查和元分析
Konstantinos Gkiouras1, Ioannis Myrogiannis2, Dimitrios Kouvelas2
1Laboratory of Clinical Pharmacology, Faculty of Medicine, School of Health Sciences, Aristotle University of Thessaloniki, Thessaloniki, Greece. kgkio@auth.gr.
Inflammopharmacology
|July 29, 2025
概括
使用布洛芬,特别是在低剂量和短时间内使用,与片或其他非选择性NSAID相比,似乎不会增加上部胃肠道出血 (UGIB) 的风险. 然而,与非用户相比,它与UGIB有关.
科学领域:
- 药理学 药理学是指药理学的学科.
- 胃肠病学 胃肠病学
- 临床研究 临床研究
背景情况:
- 以前的审查将NSAID与上部胃肠道出血 (UGIB) 联系起来.
- 缺少关于ibuprofen与paracetamol在UGIB风险上的比较数据.
研究的目的:
- 系统地审查和分析比较布洛芬与,安慰剂,非使用者或其他NSAIDs关于UGIB风险的研究.
- 评估ibuprofen使用和UGIB之间的关联.
主要方法:
- 在多个数据库中搜索RCT和观察性研究.
- 使用随机效应模型进行了元分析.
- 计算的赔率比率 (OR) 或风险比率 (RR) 具有95%的置信区间 (CI).
- 评估偏见风险和证据的确定性.
主要成果:
- 包括7个RCT和10个观察性研究 (89,522名参与者).
- 在移除异常值后,与降醇 (OR:0.96) 相比,布洛芬与UGIB无关.
- 与非使用者 (OR:2.51) 和选择性NSAID (OR:2.05) 相比,布洛芬与UGIB有关.
- 证据确定性主要是"非常低",因为存在偏差的高风险.
结论:
- 低剂量,短期使用布洛芬可能不会增加UGIB风险,而不是降醇或非选择性NSAIDs.
- 建议对剂量-反应关系进行进一步的研究.
相关概念视频
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
599
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
599
Peptic Ulcer Disease IV: Management
146
Medical treatment strategies for peptic ulcers encompass various methods. The primary goal of treatment is to diminish gastric acidity and strengthen mucosal defense mechanisms.
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
146
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
525
Peptic ulcers, often induced by H. pylori infections or NSAID usage, arise from disruptions in the delicate balance of gastric acid production. Peptic ulcers stem from heightened gastric acid levels due to H. pylori infections or NSAID use. The protective mucus layer diminishes in the presence of these factors, allowing gastric acid to erode the stomach lining and form ulcers.
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
525
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists
570
Histamine H2 receptors, which are intricately located on the basolateral membrane of parietal cells, play a crucial role in modulating gastric acid secretion. When released from enterochromaffin-like cells, histamine engages H2 receptors, initiating the cyclic AMP (cAMP) pathway. In this pathway, adenylyl cyclase converts ATP into cAMP, elevating intracellular cAMP levels. The activation of protein kinase A follows, stimulating the proton pump. This stimulation prompts the secretion of hydrogen...
570
Peptic Ulcer Disease I: Introduction
292
Peptic Ulcer Disease (PUD) is characterized by mucosal excavation in the esophagus, stomach, pylorus, or duodenum. It can manifest as acute or chronic based on the extent and duration of mucosal involvement.
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
292
Inflammatory Bowel Disease I: Ulcerative Colitis
326
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
326


